RT Journal
A1 Minder C, Blaha MJ, Tam LM, et al
T1 MAking the case for selective use of statins in the primary prevention setting
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2011
FD September 26
VO 171
IS 17
SP 1593
OP 1594
DO 10.1001/archinternmed.2011.349
UL http://dx.doi.org/10.1001/archinternmed.2011.349
AB 
We disagree that “less is more” when it comes to statins for primary prevention of cardiovascular disease (CVD). In accord with current National Cholesterol Education Program Adult Treatment Panel III (ATP III) guidelines, we believe there is compelling evidence to support the use of statins for primary prevention in patients at high risk (Framingham risk score, >10%) for developing coronary heart disease (CHD) over the next 10 years.2